Clinical Trials at CI Kherson CCH
During the past decade, CI Kherson CCH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CI Kherson CCH
According to Clinical.Site data, the most researched conditions in "CI Kherson CCH" are
"Ulcerative Colitis" (3 trials). Many other conditions were trialed in "CI Kherson CCH" in a lesser frequency.
Clinical Trials Intervention Types at CI Kherson CCH
Most popular intervention types in "CI Kherson CCH" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "ABX464" (1 trials), "ABX464 100mg" (1 trials), "ABX464 25mg" (1 trials) and "ABX464 50mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CI Kherson CCH
The vast majority of trials in "CI Kherson CCH" are
3 trials for "All" genders.
Clinical Trials Status at CI Kherson CCH
Currently, there are NaN active trials in "CI Kherson CCH".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CI Kherson CCH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CI Kherson CCH, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".